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Abstract
Without a doubt, in the past 20 or so years, we have achieved the power of biology in 
different ways. In the present, we have many tools for developing novel technologies 
and applications for organism modifications that ultimately let us know many aspects 
of organisms’ biology and, therefore, apply that knowledge for technological purposes. 
Of all the model organisms and tools for genetic modification available, Escherichia coli 
stands out as a model organism and what we would like to call “molecular biologist tool 
box.” In the present chapter, we aim to review our current knowledge regarding genetic 
modifications and tools for modifying E. coli to generate plasmid vectors, single and mul-
tiple gene knockouts, whole genome editing, biosensor generation and applications and 
synthetic gene circuits and genomes.
Keywords: molecular biology tools, synthetic biology, biosensors, plasmids, 
bioengineerging
1. Introduction
Who in biology has not heard of Escherichia coli? Known to many as the fundamental model 
microbe and perhaps model organism, E. coli is the cornerstone of many important findings 
in molecular biology and other areas of cell physiology. Perhaps even the first chemo-organo-
heterotroph had a similar mass composition as E. coli, providing the hits necessary to under-
stand the evolution of modern bacteria [1]. Also called the “workhorse” of molecular biology 
for its fast growing rate in chemically defined media and extensive molecular tools available 
for different purposes, E. coli is considered the most important model organism of them all. 
Important findings and Nobel Prizes in biology have been developed in E. coli. For instance, 
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cracking the genetic code [2], unveiling the nature of DNA replication [3], the groundbreaking 
advances on gene organization and regulation or as we love to call ‘the operon’ [4, 5], impor-
tant evidence for the basis of mutations and ultimately to the evolution of organisms [6, 7], 
and finally, the achievement of a genetically modified organism [8] that skyrocketed several 
applications of the enormous capacity for manipulating this organism, rendering E. coli as 
a key player in biotechnology (for an excellent review, see Ref. [9]).
The main reasons why E. coli is the organism of choice extends and is not limited to its 
fast growth in chemically defined media; relative cheap culture media; does not form aggre-
gates; industrial scalability; several molecular tools for manipulation; extensive knowledge of 
its genetics and genomics; extensive knowledge on its transcriptome, proteome, and metabo-
lome, and several strains are considered biosafety 1, which renders it ideal even for teaching 
and school demonstrations (for example, Bio-Rad transformation kits, URL: http://www.bio-
rad.com/es-mx/category/pglo-plasmid-gfp-kits).
Typical E. coli, a Gram-negative bacillus bears a rod-shaped, measures only about 1 μm long 
by 0.35 μm wide, although this can vary considerably depending on the strain and its condi-
tions, there are studies regarding different mutations that affect its size and length consider-
ably. A recent paper showed that this bacterium can grow up to 750 μm in length. By random 
Tn10 insertion, they found this particular mutant has an insertion at genes ybdN and ybdM 
whose function remains uncertain and another mutation that remains to be identified [10]. 
Interestingly, this mutant strain gives rise to extremely long cells that are viable (capable of 
cell division) and retain metabolic activity that can be useful for studies involving intracel-
lular localization or optimize cell-surface contact.
In terms of ecology, E. coli is a facultative aerobe (either respiration takes place in the pres-
ence of oxygen or fermentation in its absence), which bears a sensor for oxygen presence 
(redox state in the quinone pool) and can activate or repress the required metabolic enzymes, 
depending on oxygen levels [11–13]. Also, E. coli and other Enterobacteriaceae can be the 
first organisms to colonize human infant intestine due to this capacity to metabolize oxygen or 
ferment because this facultative bacteria will consume the remaining oxygen in this environ-
ment so that other strict anaerobic bacteria are capable of colonizing the intestine rendering 
the normal microbiota found in humans and also thrive as part of the normal microbiota [14].
Phylogenetically, E. coli is a member of the Enterobacteriaceae and is closely related to patho-
gens such as Salmonella, Klebsiella, Serratia, and the infamous Yersinia pestis, which causes 
plague. Although E. coli is mostly harmless, pathogenicity islands have been identified and 
associated with pathogenesis in E. coli resulting in strains that colonize different tissues [15].
The building blocks of E. coli consists of about 55% protein, 25% nucleic acids, 9% lipids, 
6% cell wall, 2.5% glycogen, and 3% other metabolites [16–18], which for biotechnological 
applications is important, since carbon flux is often a problematic issue to address in order 
to generate a novel metabolic pathway or to enhance a current functioning pathway. Also, 
carbon flux is tightly regulated by sophisticated regulatory networks that require modeling 
and a basic understanding of the regulatory mechanisms in order to manipulate them and 
achieve desired goals [19–21].
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E. coli is part of the normal microbiota of mammals, rendering the predominant facultative 
microbe of the gastrointestinal tract and is currently a hot debate on the impact on normal 
microflora establishment and their role in disease [22].
This organism lacks many interesting features for biotechnology, such as growing at extreme 
temperatures or pH, the capacity to degrade toxic compounds, pollutants, or difficult to 
degrade polymers [23]. But as we will see later, this bacterium is capable of doing amazing 
things and its only limit is our imagination.
E. coli harbors a genome with particular features such as a strikingly organized structure, rem-
nents of many phages, and insertion sequences (IS) and a high transport capacity toward the 
cytoplasm. In 1997, the complete genome sequence of the K-12 strain was obtained, and a myr-
iad of research was catapulted from that moment on [24]. The complete genome contains a sin-
gle circular duplex molecule composed of 4,639,221 bp. Regarding its structure, protein-coding 
regions correspond to 87.8% of the genome, while 0.8% encodes for stable RNAs, and 0.7% 
consists of noncoding repeats. The remaining 11% encodes for regulatory and other functions. 
Nevertheless, nearly 34% (1431) proteins are considered orphan or without defined molecular 
function but in a recent study, it was demonstrated that by homology with distant phylogeneti-
cal relationships, they may play a role in defined molecular pathways or processes [25]. From 
the orphan set in E. coli, at least 446 contain some molecular signature that can assess their 
molecular role. The fact that such a vast portion of the genome remains uncharacterized for 
defined molecular pathways or roles paves the way for future basic research that may have a 
strong impact on applied research and development. For biotechnological applications, growth 
optimization is also a required feature of genetically modified organisms. For E. coli, it has been 
recently shown that growth can be manipulated by removing nonessential genomic sequences 
that also can lead to the design of important biotechnological strains for industrial purposes [26].
The advancement of genomic, transcriptomic, and proteomic technologies has led to the 
development of several online resources for the analysis of molecular and physiological 
aspects of E. coli. Some examples are given in Table 1.
Escherichia coli databases
Name URL Description*
EcoCyc: Encyclopedia of E. coli Genes 
and Metabolic Pathways
https://ecocyc.org A comprehensive database joining 
together genomic information with 
biochemical features of E. coli
PortEco http://www.porteco.org A resource for knowledge and data 
of the biology of E. coli including 
plasmids, mobile genetic elements, 
and phages
EcoliWiki http://ecoliwiki.net/ Community-based pages about 
everything related to the biology of 
the nonpathogenic E. coli
EcoGen 3.0 http://ecogene.org/ A database dedicated to analyzing 
and comparing genomic and 
transcriptomic data
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Recently, using the Genome Conformation Capture technique, it was revealed that the linear 
organization of the genome is also true for the 3D structure, rendering neighboring genes to 
form small factories that are coregulated or coexpressed and showed a higher probability of 
forming protein-protein interactions. This organization represents two important aspects of 
bacterial genomes, first, the compactness in the 3D space, containing pathways in a nonran-
dom distribution, and second, genes that are closer to each other tend to be coexpressed and 
form protein-protein interactions favoring the concept of transcription factor even in micro-
bial cells [27].
In the following sections, we will review what we consider the modern tools for genetic 
engineering E. coli, and the future for this microbe that can be considered the toolbox for 
molecular biology and may be the answer to many problems that humanity may face in 
the future.
2. Plasmid and the E. coli revolution
Without a doubt, plasmids are the most important tools not only for the manipulation of 
E. coli but also the foundation for the genetic engineering of many organisms, cloning and 
sequencing, generation of mutants, and many applications in molecular biology. In this sec-
tion, a brief summary of the myriad of plasmids available will be addressed, providing some 
of the most important features of plasmids and the up-to-date technologies available for plas-





A powerful resource for 
understanding molecular datasets in 
different contexts, also easy access to 
gene information
RegulonDB http://regulondb.ccg.unam.mx Database on transcriptional 
regulation in E. coli K-12 containing 
knowledge manually curated from 
original scientific publications, 
complemented with high throughput 
datasets and comprehensive 
computational predictions
E. coli Genetic Stock Center http://cgsc.biology.yale.edu/ The CGSC Database of E. coli genetic 
information includes genotypes and 
reference information for the strains 
in the CGSC collection. An excellent 
resource for acquiring information 
and strains for research
*Source: databases website.
Table 1. Relevant E. coli resources and databases.
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Why plasmids are the basis for genetic engineering? By surveying the literature and com-
mercial sources catalogs, there is a myriad of applications for plasmids: cloning, mutagenesis, 
protein fusion and overexpression, shuttle vectors from bacteria to a diverse range of hosts, 
among others. Plasmids must be first presented and then we provide some features that are 
relevant regarding the importance of plasmids in molecular biology and biotechnology.
Plasmids are extrachromosomal molecules that are self-replicative and sometimes provide 
interesting features to its host. The term was first coined by Joshua Lederberg in 1952 refer-
ring to genetic elements in bacteria that remained as an independent molecule from the chro-
mosome at any stage of their replication cycle [28]. The definition was further refined to all 
the autonomously replicating DNA molecules to avoid including viruses. These molecules 
are present not only in eubacteria but also are found in Archea and some lower eukaryotic 
organisms [29]. In nature, many bacteria contain self-replicating DNA molecules that can be 
harnessed for molecular biology applications. E. coli plasmids were the first ones to be exten-
sively modified for such purposes [30].
In the 1970s, the first generation of cloning plasmids was created, and from that moment on, 
research in the biological area was enriched with a powerful tool. Plasmids must contain sev-
eral important features to be used in research: proper size for ease to transform or transfect, 
selection markers, a replication origin, regulatory elements to control expression, and tran-
scription termination. All features are important when designing a plasmid vector for the 
desired application, the reader can imagine the goal, and there will always be a way to create 
the molecular tool for achieving such a goal, and that is possible due to the basic structure of 
most plasmids used in molecular biology and their modularity [31]. In Table 2, we summarize 
some of the most important features (modules) that plasmids must have in order to serve for 
different applications. We point out that sequence composition and structure, copy number, 
selection marker, and special features such as reporter proteins or regulatory elements are the 
most important features in a plasmid and can influence the outcome of the desired application.
Escherichia coli plasmids
Name Type of element Characteristics
ColE1 Replication origin Generates 15–20 copies of each 
plasmid molecule. Colicin 
production. Related to plasmids that 
confer immunity to phage infections 
[32]. Found in low copy plasmids 
such as pBR322 [33]. There are 
mutations in this replication origin 
that leads to high copy number 
plasmids, such as pUC series that 
can render up to 700 copies per cell 
[34, 35]
p15A Replication origin Low copy number replication origin, 
estimated in 18–22 copies per cell 
[36]. This type of replication origin 
is often found in pACYC and its 
derivative vectors
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Some exceptional features of plasmids are they can be used in systems where replication ori-
gins (check compatibility first) and selection markers can coexist in the same cell, which can 
be extremely useful for the coexpression of four different proteins in the same cell (e.g., the 
four plasmid system developed by Dykxhoorn et al., which are compatible between them 
[41]); the broad diversity of selection markers and partitioning control elements [30]; cloning 
capacity [31], which is an important feature for cloning large fragments required for synthetic 
biology applications or metabolic engineering; reporter proteins useful for selecting positive 
clones; recombination or assembly technology for easier cloning methods [42, 43], and the 
Escherichia coli plasmids
Name Type of element Characteristics
pMB1 Replication origin Versatile replication origin. The 
original sequence generates 15–20 
copies per cell, but a mutant version 
can lead up to 700 copies per cell 
[37]. This plasmid contains the EcoRI 
restriction-modification system
pSC101 Replication origin Five copies per cell [38]
R6K Replication origin 15–20 copies per cell. Requires 
the π protein from the gene pir 
for replication [39]. This origin of 
replication is functional in diverse 
bacterial species
Ampr, Kanr, Cmr, Tetr among other Selection markers Elements required for the selection 
and maintenance of plasmids in 
bacterial hosts. Here are listed the 
resistance cassettes for Ampicillin, 
Kanamycin, Chloramphenicol, and 
Tetracycline, which are the most 
common selection markers. For 
additional markers, RAC database 
contains the information regarding 
antibiotic resistance traits and their 
sequence [40] or iGEM website for 
sequence modules bearing the proper 
syntax for synthetic constructs
LacZ, CcdB, Green Fluorescent 
protein (GFP), etc
Additional elements required for 
positive clone selection, reporter 
protein fusions among others
Plasmids have been modified so 
that they contain multiple cloning 
sites with diverse unique restriction 
sites, counter selection for positive 
clone selection. Additional elements 
such as filamentous origins for 
single-stranded DNA generation for 
sequencing of high G+C templates or 
site-directed mutagenesis
Additional sources: [31], http://blog.addgene.org/plasmid-101-origin-of-replication. https://www.neb.com/, https://
www.thermofisher.com/mx/es/home/brands/invitrogen.html, and http://parts.igem.org/Help:Synthetic_Biology, which 
contains a repository of parts that can be needed for plasmid construction using synthetic methods.
Table 2. Common elements in plasmids used in molecular biology applications.
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ability to be transferred from one host to another like the case of the OriV from RK2 plasmid 
[44]. We recommend for further information about replication control of plasmids to refer to 
del Solar et al. [45].
Linear plasmids are common in bacteria (particularly in actinobacteria), but thus far, only 
N15 plasmid prophage has been isolated from E. coli [46] and is an impediment for generating 
knockouts using linear DNA (see Section 3). Recently, a linear plasmid was created to clone 
unstable fragments bearing repetitive sequences without showing size bias during cloning, 
active promoter sequences, or sequences with A + T content [47].
One of the biggest impediments for plasmid segregation is the insert size. As discussed in 
Section 5, we are now facing not only the most exciting age of molecular biology but also 
the most challenging. In order to develop “bugs to the order,” i.e., microbes are “trained” 
to perform specific tasks [48], from simple pathways to synthesize a specific metabolite to 
complex genetic circuits that can be controlled for novel environmental responses. In all these 
cases, plasmids play an important role, from generating site-specific integration of chromo-
somal fusions to large plasmids that can hold complex constructs for further modification. 
Another challenging area is the generation of strains capable of producing metabolic products 
required for the pharmaceutical industry, where metabolic pathways and cell metabolism 
can be a strong impediment for proper synthesis and purification of relevant precursors [49]. 
E. coli renders an important platform for tackling down impediments for the synthesis of 
novel compounds.
As part of the information needed for plasmid manipulation, databases and repositories are 
also relevant for the manipulation and selection of the right plasmid for the applications you 
want to further exploit. Such examples are given: a powerful plasmid repository is Addgene 
(https://www.addgene.org/vector-database/) where you can get any plasmid in the reposi-
tory with minimum fees for shipping and handling. This source is important in many aspects; 
you can gain knowledge about plasmid sequence, special features, creators, and availability 
to use since you can acquire them with small fees. Also, Harvard University is currently gen-
erating a plasmid repository but still under development (https://plasmid.med.harvard.edu/
PLASMID/Home.xhtml). These repositories are an excellent option for accelerating research 
due to finding already generated constructs useful for ongoing projects. Also, E. coli Genetic 
Stock Center (Table 1) is a good source of strains and plasmids for different applications. 
For a small fee, the strains and plasmids can be shipped worldwide and characteristics can 
be consulted. Also, the American Type Culture Collection (www.atcc.org) is a source for 
strains with desired characteristics, as well as knowledge on their features. In plasmid biol-
ogy, strain selection is fundamental for plasmid stability and proper propagation, as well as 
for the correct function of special features, such as protein expression [50]. For example, DNA 
methylation is an important impediment in certain applications such as eukaryotic transfec-
tion, proper DAM− and DCM− strains for plasmid isolation is required. In protein expression 
experiments, the repertoire for host selection is big. Most applications require lysogen strains 
harboring the required RNA polymerase. As stated in Table 2, some plasmids require the 
product from the pir gene, so careful strain selection must be taken into account so that plas-
mids replicate efficiently.
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Novel methods such as Gibson assembly, Golden Gate assembly, and AQUA (advanced quick 
assembly) methods [43, 51, 52] have skyrocketed the possibility to assemble any plasmid with 
the desired characteristics. These methods are based on designed modules that can either be 
Polymerase Chain Reaction (PCR) amplified or generated as a complete synthetic construct 
and then assembled in the desired combination either by an enzymatic process (Gibson and 
Golden gate) or even enzyme-free methods such as AQUA.
Finally, plasmid biology is still under scrutiny, for their involvement in the mobility of traits 
that are important for human health such as antibiotic resistance, the distribution of patho-
genicity islands, and genome evolution. Recently, novel tools for plasmid mining have been 
developed and uncover from Next Generation Sequencing data that plasmids can be uncov-
ered and analyzed for further characterization [53, 54].
We are still in the process of truly knowing the potential of E. coli, novel tools generated through 
plasmids in combination with other molecular strategies will lead to new discoveries that will 
render this organism the basis for important discoveries. In the next section, we will discuss 
some aspects of gene knockouts and the knowledge we have gained from this versatile organism.
3. Genome modifications to understand E. coli
One of the basic questions in biology is: what is life? Defining life imposes a challenging bur-
den both intellectual and experimental. Many attempts have been done to answer this. E. coli 
is a model organism that with all the molecular tools available we can get a step closer to pro-
vide sufficient information that will lead us to answer the relevance of genomic information 
and ultimately what is needed to achieve life [55]. In 1997, its genome was fully sequenced, 
and with all that information (from E. coli and all the organisms that have been sequenced 
thus far), scientists have aimed high to achieve the knowledge of how many genes are needed 
for life to be sustained. Molecular genetics have provided many tools for understanding gene 
structure and function, the most fundamentals are gene knockouts and genome deletions. In 
this section, we provide aspects that are fundamental for understanding genome structure 
and function taking our knowledge closer to knowing the minimal core genome of bacterial 
organisms and the optimization of E. coli for biotechnology.
In E. coli, several tools for genome modification have been developed. Some of the most impor-
tant methods involve either the generation of deletion mutants by removing specific genes, 
one outstanding case is the use of the lambda Red system for inhibiting linear DNA degra-
dation and by homologous recombination, the deletion of specific genes using PCR-derived 
selection marker cassettes with homologous sequences with target gene [56, 57]. Lambda Red-
based method have yielded a total of 4288 genes mutated without lethality (Keio collection), 
303 genes were unable to be deleted, from which 37 are of unknown function [58]. This experi-
mental evidence has pointed out one very important aspect of genome structure and function. 
Genome size increase is the result of horizontal gene transfer or DNA fragment retention that 
somehow is giving some beneficial features to recipient host, apparently an increase in fitness 
[26]. The function of genes without evident function is still a relevant area of research since 
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many of them provide support for fitness and evolution has preserved them, therefore full 
genome engineering is far more complicated than previously thought.
Larger genomic editions are needed to understand how far we can delete redundant or non-
essential sequences. By using Cre/lox recombination, substantial genomic fragments can be 
deleted or sequentially removed, rendering the nonessential regions (regardless the genes 
present) from the genome [59–61].
Studies regarding genome size analyzed through deletions of specific genes or complete 
genomic regions have led on thinking about the minimal genome. In the case of E. coli, there 
are several pieces of evidence (reviewed in Ref. [62]) that points out that at least 23% of the 
genome can be eliminated gaining genomic stability and normal growth. Also, eliminat-
ing insertion sequences can enhance the capacity of E. coli to synthesize proteins due to the 
decrease or insertions on plasmids, and strains exhibit normal growth plus increased genome 
stability [63].
All these methods rely on basic bacterial genetics founded with E. coli, such as transposon-
based integration of recombination sequences, λ-recombination of PCR products integrating 
deletion module cassettes, and the gene-specific knockout methods [62]. Mutations can then 
be transferred from one strain to the other to generate multiple deletions at once, and other 
technologies are still limited to either whole genome synthesis with previous knowledge on 
the structure of the genome.
The most relevant study revealed that genome size has an impact on E. coli cell growth, where 
it is shown that apparently dispensable sequences are needed under restrictive conditions, 
providing a hint of the still far future of fully functioning cells with all the desired character-
istics for biotechnological applications [26]. We envision that genome reduction is a worthy 
effort, regardless of the method used to generate them. Another important aspect that we 
have to consider is that all conditions of the mutant strains are exposed to laboratory condi-
tions rendering a behavior close to the ancestor or original strains. Nevertheless, there are 
also hidden features that must be exploited in order to understand fully the behavior of the 
genome and the essentiality of genes [62]. Thus far, E. coli remains restricted to the use of clas-
sic genetic tools and transposon or plasmid-based techniques. We encourage E. coli research 
community to join efforts to enter the synthetic biology era, toward the generation of a fully 
synthetic E. coli. Our excitement is based on the following:
After 6 years, in 2016, the first bacteria operating under a “minimal chemically synthesized 
genome” was created after the first fully functioning synthetic genome [64, 65].
This research we believe has an impact in the following areas. First, both studies settled the 
basis for whole genome synthetic biology, which will lead to important findings in many 
research areas. Second, the extensive transposon-based mutagenesis studies on the genome 
of Mycoplasma mycoides led to the knowledge of the basis of essential genes or quasi-essential 
genes that have an important impact on cell fitness. Third, all this knowledge led to the 
design of a complete chemically synthesized genome with all the basic functions, and we 
now have the basic information for mining existing genomes to look for core modules in 
the bacterial genomes and design genomes with specific functions. Taking together all the 
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observations from the synthetic genomes, we envision a bright future for bacterial molecular 
genetics in many fields of biotechnology, such as the production of molecules for human 
wellbeing.
E. coli is an extensively studied organism, with all the cumulative data we can ensure that 
with all this knowledge, we can design tools. In the following section, we comment on the 
biosensors that are E. coli-based.
4. E. coli-based biosensors: tools for many applications
In biotechnology, biosensors are broadly defined as any device based on biological part, cell, 
tissue, or protein complex that are linked to a mechanical sensor or analytical receptor that pro-
vides a measurable signal proportional to the analyte in the reaction [66, 67]. E. coli-based bio-
sensors using plasmid or chromosomal constructs are useful for the detection of environmental 
traits or hazards or measuring cellular processes as any standard reporter system [68–70].
In Figure 1, we depict the basic design for whole-cell biosensors and some applications. 
Plasmid vectors with all the possible modifications can lead to almost endless combinations. 
For practical applications, there are commercial vectors that can be used for such purposes 
or as mentioned in the previous sections, plasmid methods are powerful enough for fast and 
robust biosensor design.
Figure 1. Basic principles for biosensor design. First, the proper design and the experimental creation of reporter strains. 
With current knowledge, either plasmid creation or whole genome engineering can lead to the creation of a reporter 
strain. Second, incorporation of such elements into the host cell. Third, sensing module and response measurement. 
With current reporter proteins and detection technology, it is relatively easy to generate biosensors that can be used in 
different applications with high sensitivity and selectivity.
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The basic design considers the following: copy number, reporter proteins, detection meth-
ods, and control elements. The latter is basically the most important feature. As shown in 
Table 1, the available databases provide enough information for promoter selection and 
design. Bioinformatic tools can make this process easier [71]. Also, generation and detection 
of this kind of biosensors are cost-effective and easy to generate and reasonably sensitive [71]. 
In terms of speed, sample analysis with whole-cell biosensors is fast and cheap in comparison 
with analytical methods. The sensitivity of analytical methods is higher and more accurate, 
but biosensors are a good alternative for fast detection of hazards. Also, they can be coupled 
with the controlled production of metabolites of commercial importance.
In the literature, there are several reports where E. coli-based biosensors have been success-
ful for detecting different traits: oxidants [72, 73], DNA damaging compounds [74], mem-
brane-damaging compounds [75], protein-damaging compounds [76], aromatic compounds 
[77–79], xenobiotics [80], antibiotic panels using reporter strains without antibiotic selection 
[81], etc. The only limitation is the available sensor module and the design. The reporter pro-
tein is also important. Stability and reproducibility are two important aspects of biosensor 
design. In our experience, Green Fluorescent protein (GFP) protein is superior to luciferase, 
especially that we can detect GFP by various methods (we find flow cytometry, fluorometry, 
and confocal microscopy our top preferences) without cell lysis or substrate mixtures that are 
time-consuming [82].
With the improvement of DNA synthesis, recoding protein-coding genes for the desired func-
tion is expanding the capabilities of transcription factors, and reporter proteins have created 
novel sensor modules. For example, XilR recoding has led to a sensor that can detect mil-
limolar concentrations of trinitrotoluene and its derivative compounds [83]. By using shuttle 
vectors, we can generate biosensors that we can transfer from one host to another, which 
can provide information about differences in physiological responses during the exposure to 
a given environmental trait.
E. coli plasticity and tools such as BioBrick building (using standardized DNA fragments with 
compatible ends for fast assembly) can facilitate plasmid and reporter constructs [84, 85]. 
Correlations of cell growth and physiology with expression patterns from reporter constructs 
can expand our knowledge of the impact of exposure to the external stimulus on cell physiol-
ogy. Biosensors based on whole cells are a cheap alternative and can be coupled to portable 
devices. Using qualitative reporters can be applied in field research [70]. One good example 
is the detection of parasites without using cold-protected samples or complicated equipment 
for the detection process [86].
In the following section, we provide our final overview of the impact of E. coli in the synthetic 
biology future.
5. Genetic engineering and synthetic biology of E. coli
With the avenue of in vitro DNA synthesis to generate larger fragments with increased fidelity 
along with novel assembly methods, we are now capable of generating large and custom-
made DNA molecules with the desired properties or even without the source of a DNA sample 
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 having only the sequence itself. New biological parts (genes, promoter sequence, terminators, 
etc.), devices (gene networks), and modules (biosynthetic pathways) are only limited by our 
imagination and the drive to create them. Also, without the advancement of methods for ana-
lyzing large amounts of data, bioinformatics, codon optimization software, genome mining, 
and user-friendly databases, synthetic biology creations are permeating in many laboratories 
around the world. With this in mind, we will review the current technologies for synthetic 
genes and genomes, and how this technology can be applied in generating novel regulatory 
circuits and even whole genomes. In this regard, E. coli is the key organism for such endeav-
ors. Why? Well, in this section, we provide some examples that we consider may be helpful in 
the future of mankind and are in our opinion relevant in the field of genetic engineering and 
synthetic biology.
Synthetic biology is a relatively new branch of molecular genetics that incorporate engineer-
ing principles for modifying several aspects of cell physiology, rewiring genetic circuits, cre-
ating novel circuits, and synthesizing custom-made DNA sequences and even genomes [87]. 
This particular branch of biology needs to be supported by an extensive knowledge of the 
organism that modifications or even whole genome synthesis is attempted, several novel tools 
for analyzing big datasets and molecular tools for that particular organism, for the genera-
tion of sequences and the computational design of DNA molecules, and a goal that can be 
achieved with the desired organism. E. coli along with Saccharomyces cerevisiae are the most 
studied and well-comprehended organisms in science, and diverse phenotypes have been 
identified that are helpful for bioengineering [88, 89].
Multiplexing is the novel approach for redesigning organisms to do desired tasks [90]. By 
cycling through design-build–test framework we can achieve novel features in existing 
proteins and can further the advancement of genetic engineering. Thus far the most com-
plicated and time-consuming part of this framework is the testing of the novel designs. High-
throughput approaches have led to the development of fast and reliable screening methods 
and advances in this area, such as designed biosensors for the screening of metabolite produc-
ing strains or high-throughput methods for product screening, where the use of fluorescent 
proteins, colorimetric assays, and mass spectrometry are cornerstones for the development of 
screening methods for assessing success in strain engineering [90, 91]. DNA sequencing and 
synthesis coupled with good screening methods is the platform for future tools for the devel-
opment of designed microorganism that can do desired tasks.
With all the technologies available, the advancement of using E. coli for biotechnological 
applications based on synthetic approaches have led to the development of strains capable 
of synthesizing several novel compounds. In the following lines, we provide some examples 
that we find important for improving environmental conditions and human well-being.
Synthesis of important metabolites can be difficult, and researchers must face the stubborn-
ness of microorganisms to redirect carbon flux to their own processes, rendering the pro-
duction of relevant molecules costly and inefficient. But E. coli is a flexible platform for the 
efficient production of molecules for the pharmaceutical industry, metabolites and molecules 
relevant for food additives, pigments, and more recently complex aliphatic molecules [92].
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Several aromatic compounds have been successfully synthesized in E. coli due to their 
biological activities (vitamins and antioxidants, for example), pigmentation (applied in 
different industrial processes), and fragrance etc. [93]. In the case of the perfume indus-
try, the synthesis of other relevant compounds such as precursors for Ambrox, a highly 
appreciated odorant for the perfume industry, or the synthesis of Geraniol, a valuable 
acyclic monoterpene alcohol, is also used in the perfume industry and pharmaceutical 
applications [94, 95].
Another relevant area was E. coli stepping in to biofuel production. The twentieth century is 
characterized by the human dependence on fossil fuels. They participate in a myriad of pro-
cesses, and the demand is increasing. In order to alleviate the demand, scientists have turned 
to the development of novel technologies for biofuel production by the conversion of car-
bon sources into usable fuel. There are several reports where E. coli have been successfully 
engineered for the synthesis of branched-chain fatty acids or short-chain fatty acids that can 
ultimately lead to the mass production of fuel precursors or useful materials derived from 
oil [96–98]. Perhaps, the most promising future is a fully replicated fossil fuel, i.e., a mixture 
structurally and chemically identical to the fossil fuels that are currently under use, which is 
a mixture of aliphatic n- and iso-alkanes of various chain lengths [99]. Also, a more complete 
metabolic atlas of E. coli is needed, and recent efforts have mapped the metabolic flux from this 
bacterium further [100].
Another important field where E. coli is making an important contribution powered by 
synthetic biology is the antibiotic production. From the biomedical standing point of view, 
increasing antibiotic resistance in pathogens is a burden for humankind, and the discovery 
of novel compounds is a time-consuming task. Recent efforts with known polyketides have 
started to give good production rates in E. coli, favoring the process of antibiotic production 
from different sources, eliminating the need for host growth standardization, and inducing 
conditions [101].
Due to the modularity of polyketide synthases, they are excellent candidates for engineer-
ing, for either the production of novel compounds from existing gene clusters (through mod-
ule shuffling, mutagenesis or deletions), or by the introduction of novel environmentally 
sequenced gene clusters and heterologous production [102, 103]
Therefore, the production of diverse metabolites or biological or industrially relevant mol-
ecules can be successfully achieved in E. coli. Success stories have been published more fre-
quently. With the advancement of high-throughput technologies, more sensitive detection, 
and analytical tools, and better DNA synthesis, the future for E. coli is brilliant.
6. Future
With all the research that is currently conducted in E. coli, we envision that the future for 
this versatile microbe is bright. Gained knowledge on E. coli is overwhelming, nearly 340,000 
research papers with the “Escherichia coli” keyword available in Pubmed, versus 115,000 using 
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“Saccharomyces cerevisiae” as a keyword for an example. Several genomes from environmental 
sources have been sequenced. Thousands of research papers aimed to assess the metabolic 
and genetic potential of this organism have been published. Now we need to start joining 
forces for boosting the true potential of this wonder microbe.
With all the data available, we are on the verge of really important findings and novel biotech-
nological procedures using E. coli. Recently, with an extensive analysis of human microbiota, 
we are approaching exciting times where all the knowledge can be applied to help people 
during certain diseases related to colon microbiota imbalances [104]. Findings suggest that 
microbiome can be manipulated to improve certain metabolic pathways [105].
In the rest of the biotechnology fields, we have enough information that suggests E. coli will be 
in the spotlight for quite some time. Even with novel organisms that have been proposed to sub-
stitute it, like Vibrio natriegens. Recently, Lee and collaborators analyzed the genome sequence 
and growth properties of the fast-growing bacterium V. natriegens [106], where authors created a 
novel platform for genetic engineering in one of the fastest growing bacteria. In previous reports, 
it has been shown that V. natriegens are capable of being transformed with E. coli plasmids [107], 
rendering that all the molecular tools available thus far may be compatible with this new sys-
tem. This bacterium as E. coli renders only one important drawback: it may be pathogenic to 
oysters [108]. But as with old E. coli, we should be careful when managing genetically modified 
organisms. With recent efforts to generate lab-contained organisms, E. coli mutants that can only 
survive in the presence of synthetic amino acids have been created [109]. Despite all the molecu-
lar tools developed so far for E. coli, the future is still open for a novel molecular toolbox. Until a 
novel toolbox is standardized and incorporated into the everyday life of the laboratories around 
the world, we will keep exploiting the capabilities of E. coli, one wonderful bug.
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